Literature DB >> 17713423

Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing.

Enrico Girardi1, Caroline A Sabin, Antonella D'Arminio Monforte.   

Abstract

A substantial proportion of HIV-infected individuals do not present for HIV testing until late in infection; these individuals are often ill, have a high mortality risk, and are less likely to respond to treatment when initiated. Furthermore, late presentation means that opportunities to reduce onward transmission, either by reducing high-risk behaviours or by reducing an individual's infectivity, are missed. The proportion of HIV-infected individuals who present late has remained relatively stable over the past decade, despite several attempts to encourage earlier diagnosis. Late presenters tend to be those at lower perceived risk of infection, those who are not routinely offered HIV testing, and are often from marginalized groups. Strategies that encourage earlier testing, including routine HIV testing in healthcare settings where high-risk individuals attend frequently, the availability of HIV testing services in non-medical settings, and partner notification schemes or peer-led projects to encourage high-risk individuals to attend for testing, may all increase the proportion of HIV-infected individuals who are aware of their HIV status, thus helping to control the spread of the epidemic. This review summarizes recent evidence on the epidemiology of late presentation and its impact on clinical progression, and describes several key strategies that may encourage earlier diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713423     DOI: 10.1097/01.qai.0000286597.57066.2b

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  133 in total

Review 1.  When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

Authors:  Philip M Grant; Andrew R Zolopa
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  Missed opportunities for HIV screening in pharmacies and retail clinics.

Authors:  Caitlin Dugdale; Nickolas Zaller; Jeffrey Bratberg; William Berk; Timothy Flanigan
Journal:  J Manag Care Spec Pharm       Date:  2014-04

3.  Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART).

Authors:  T R Kiderlen; O Liesenfeld; D Schürmann; T Schneider
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

4.  [Delay in the diagnosis of HIV infection in Spain: can we tackle this epidemic in primary care?].

Authors:  Lucía García San Miguel; Maria José Busto Martínez; Elena Bermúdez Moreno
Journal:  Aten Primaria       Date:  2009-03-25       Impact factor: 1.137

5.  Predictors of human immunodeficiency virus (HIV) infection in primary care among adults living in developed countries: a systematic review.

Authors:  Benhildah N Rumbwere Dube; Tom P Marshall; Ronan P Ryan; Modupe Omonijo
Journal:  Syst Rev       Date:  2018-06-02

6.  Social Capital is Associated With Late HIV Diagnosis: An Ecological Analysis.

Authors:  Yusuf Ransome; Sandro Galea; Roman Pabayo; Ichiro Kawachi; Sarah Braunstein; Denis Nash
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

7.  Periconception pre-exposure prophylaxis to prevent HIV transmission: benefits, risks, and challenges to implementation.

Authors:  Lynn T Matthews; Jared M Baeten; Connie Celum; David R Bangsberg
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

8.  HIV prevalence, substance use, and sexual risk behaviors among transgender women recruited through outreach.

Authors:  Cathy J Reback; Jesse B Fletcher
Journal:  AIDS Behav       Date:  2014-07

9.  Early mortality and cause of deaths in patients using HAART in Brazil and the United States.

Authors:  Beatriz Grinsztejn; Valdilea G Veloso; Ruth K Friedman; Ronaldo I Moreira; Paula M Luz; Dayse P Campos; José H Pilotto; Sandra W Cardoso; Jeanne C Keruly; Richard D Moore
Journal:  AIDS       Date:  2009-10-23       Impact factor: 4.177

10.  Late-stage disease at presentation to an HIV clinic in eastern Tanzania: A retrospective cross-sectional study.

Authors:  H Mhozya; D Bintabara; S Kibusi; E Neilson; B C Mpondo
Journal:  Malawi Med J       Date:  2015-12       Impact factor: 0.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.